Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877667 · ClinicalTrials.gov registry record · NA
Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol
A NA study of Tattoo, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02877667: Completed NA study of Tattoo, sponsored by Soliton.
NCT02877667 is a NA study of Tattoo that has completed, run by Soliton. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877667, a NA study of Tattoo, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.
Primary Outcome
Safety assessments included reported Adverse Events as a result of physician examination
Conditions Studied
Interventions
- DEVICE planar acoustic wave device
Study Locations (1)
Massachusetts
- SkinCare Physicians - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
What the finished NCT02877667 record still lists
NCT02877667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Tattoo appearing as the primary indexed condition, and to 1 intervention - of which planar acoustic wave device is the first listed.
NCT02877667 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02877667 about?
NCT02877667 is a clinical study titled "Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol". Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.
What is the current status of trial NCT02877667?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-07. Estimated completion is 2017-04-30.
What conditions does trial NCT02877667 study?
This clinical trial studies the following conditions: Tattoo.
What interventions are being tested in trial NCT02877667?
The interventions under investigation include: planar acoustic wave device (DEVICE).
Who is sponsoring clinical trial NCT02877667?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02877667 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02877667's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia